TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Regulatory News: TME Pharma N.V. , a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment , announced today that the annual...